🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Healthy Women Volunteers

A Phase 1 Study of CLYM116 in Normal Healthy Volunteers NCT07248865Phase 11 site📍 Brisbane Climb Bio, Inc. · Tests: CLYM116, Placebo Evaluating a Mat-Based Biometric Vibration System for Sleep and Daily Recovery NCT07221318NA1 site📍 Miami Florida International University · Tests: Low-frequency whole-body vibration mat Ayahuasca, Esketamine and Premenstrual Symptoms NCT07317232NA1 site📍 Ribeirão Preto University of Sao Paulo · Tests: Ayahuasca, Esketamine Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers NCT07207291Phase 11 site📍 Changsha Joincare Pharmaceutical Group Industry Co., Ltd · Tests: JKN2501, Placebo Effect of Acute Hypoxia on Renal Hemodynamic in Healthy Volunteers, Patients With Diabetes and Patients With Diabetes and Kidney Disease NCT06846034NA1 site📍 Poitiers Poitiers University Hospital · Tests: Hypoxia administration study group, Renal clairance study Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL) NCT06664827NA1 site📍 Houston The Methodist Hospital Research Institute · Tests: Delfi PTS Blood Flow Restriction Tourniquet System Endothelial Function in Healthy Volunteers NCT07837076NA1 site📍 Clermont-Ferrand University Hospital, Clermont-Ferrand · Tests: Measurement of endothelial function using FMD Phase 1a Study Assessing Safety, Tolerability, Pharmacokinetics, and Immunogenicity of PMG1016 NCT07615985Phase 11 site📍 Brisbane Pulmongene Ltd. · Tests: PMG1016 Dose 1, PMG1016 Dose 2, PMG1016 Dose 3, PMG1016 Dose 4 Vasopressin and Pain Perception in the Brain NCT03446456Phase 1, Phase 21 site📍 Baltimore University of Maryland, Baltimore · Tests: Arginine vasopressin, Saline, Observational learning, fMRI data aquisition The Effects of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Anxiety Responses and Emotional Regulation NCT07369908NA1 site📍 Chengdu University of Electronic Science and Technology of China · Tests: taVNS on tragus of subjects with high trait anxiety, taVNS on earlobe of subjects with high trait anxiety, taVNS on tra… Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging NCT07225114Phase 21 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: contrast agent perflutren lipid, Ultrasound Imaging A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years NCT07413666Phase 11 site📍 Lincoln Centessa Pharmaceuticals (UK) Limited · Tests: ORX489 Tablets, Placebo Tablets Development of an Improved Method of Measuring Total Body Bone Perfusion Using Total-body PET/CT NCT07860346n/a1 site📍 London King's College London · Tests: 1-hour Total Body PET/CT scan using the tracer [18F]-sodium fluoride A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function NCT07315360Phase 14 sites📍 Lake Forest📍 Orlando📍 Tampa Pfizer · Tests: PF-07328948 Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease NCT06989320NA2 sites📍 Birmingham📍 Dallas University of Alabama at Birmingham · Tests: Low-oxalate diet and glycolate dosing, Oral glycolate dosing, Oral 13C- ascorbic acid dosing Urinary Vitamin C Loss in Diabetic Subjects NCT00071526n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol NCT07269873Phase 11 site📍 Miami BioCorRx Pharmaceuticals Inc · Tests: BICX104 naltrexone implantable pellet, Bupropion 150 mg XL, Naltrexone (depot) Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease NCT07473323Phase 11 site📍 Melbourne Mediar Therapeutics · Tests: MTX-439, Placebo Healthy Volunteers Study NCT06962059n/a1 site📍 Philadelphia Abramson Cancer Center at Penn Medicine · Tests: Self-Administered Sample Collection BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants NCT06741072Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Dulbecco''s Phosphate-Buffered Saline, Peptide Vaccine, QS21 A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions: NCT07201584Phase 11 site📍 Almaty Berlin-Chemie AG Menarini Group · Tests: Torasemide tablet 10 mg, Unat® 10 tablets (Torasemide 10 mg) Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors NCT04354064n/a1 site📍 St Louis Washington University School of Medicine Near-InfraRed Spectroscopy of Auricular Stimulation NCT06825364NA1 site📍 Pittsburgh University of Pittsburgh · Tests: auricular stimulation Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia NCT07317544Phase 1, Phase 25 sites📍 Sydney📍 Brisbane📍 Melbourne Absci Pty Ltd. · Tests: SAD IV Dose 1 - 150mg ABS201 IV Single Dose, Placebo IV, ABS-201 SC Multiple Doses, Placebo SC Injection A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants NCT07497503Phase 11 site📍 Bayswater Syneos Health · Tests: Forsteo®, B-3E07 Ayahuasca, Esketamine and Body Image Perception NCT07317219NA1 site📍 Ribeirão Preto University of Sao Paulo · Tests: Ayahuasca, Esketamine Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults NCT07144527NA1 site📍 Beverly Hills Scott Silveira · Tests: NMN and TMG (Euexia), Nicotinamide Mononucleotide (NMN), Placebo Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease NCT07235059Phase 12 sites📍 Miami📍 Berlin Novartis Pharmaceuticals · Tests: OJR520, Placebo Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interactions NCT07251153Phase 11 site📍 Gières Enyo Pharma · Tests: EYP651/Vonafexor low dose, EYP651/Vonafexor high dose, EYP651/CYP3A4 inhibitor, EYP651/Transporter substrate, EYP651/CY… Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers NCT06995482Phase 12 sites📍 Miami Lakes📍 Pune Kashiv BioSciences, LLC · Tests: KSHN001034, KSHN001034, KSHN001034, KSHN001034, KSHN001034
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy